VRCA
Verrica Pharmaceuticals Inc. - Common Stock (VRCA)
$46
About Verrica Pharmaceuticals Inc. - Common Stock (VRCA)
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Details
Daily high
$3.50
Daily low
$3.31
Price at open
--
52 Week High
$9.82
52 Week Low
$3.20
Market cap
56.5M
Dividend yield
-
Volume
443
Avg. volume
54,326
P/E ratio
-1.97
Verrica Pharmaceuticals Inc. - Common Stock News
Details
Daily high
$3.50
Daily low
$3.31
Price at open
--
52 Week High
$9.82
52 Week Low
$3.20
Market cap
56.5M
Dividend yield
-
Volume
443
Avg. volume
54,326
P/E ratio
-1.97